Clinical Trial Update: Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism

View source ↗

Summary

A clinical trial update describes an observational study of intranasal IVIG for patients with post-acute sequelae of SARS-CoV-2 infection (Long COVID), currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Intranasal IVIG (intranasal immunoglobulin)

Snippet

Sponsor: Tamara C Tamas | Conditions: Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID | Status: NOT_YET_RECRUITING